Redeye: Speqta - Increasing Cash Position to Finance Growth Initiatives
Redeye retains its positive view of Speqta despite slightly lowering its forecast and Base Case. While the net store intake came in somewhat below our expectations, with its strengthened cash position, we believe increased investments in sales will fuel growth in 2023.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/